Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 5 | BMC Cancer

Fig. 5

From: Clinicopathological implications of Tiam1 overexpression in invasive ductal carcinoma of the breast

Fig. 5

Kaplan-Meier analyses of survival rates in patients with high- or low-level Tiam1 expression and with early- or late-stage breast cancer. DFS (a) and OS (b) rates were assessed in patients with early-stage breast cancer concomitant with either high- (green, n = 26) or low-level (black, n = 58) Tiam1 expression. DFS (c) and OS (d) rates were also assessed in patients with late-stage breast cancer concomitant with high- (blue, n = 39) or low-level (red, n = 30) Tiam1 expression

Back to article page